Abstract

BK polyomavirus (BKV) is a challenging problem for the transplant nephrologist. Various strategies have been used to prevent or treat BK virus nephropathy (BKVN). These include reduction in immunosuppression, intravenous immune globulin, cidofovir, leflunomide, and the fluoroquinolone antibiotics. All these agents have their own toxicities. Great interest was shown to use fluoroquinolones to prevent BKVN after its useful experience was reported in bone marrow transplant. Fluoroquinolones being cheap and easily available, attracted nephrologists to use it, for prevention of BKVN. These agents have been shown in vitro studies to be effective. However, there are mixed results about their effectiveness in prevention of BKVN in clinical setting. This review will focus the evidence available for using fluoroquinolones in prevention of BKVN and its usefulness. Furthermore, a way forward to use these agents or not for prevention of BKVN will also be discussed.

Details

Title
Fluoroquinolones and BK virus nephropathy: A myth or a reality
Author
Khalil, M. A. M 1 ; Khalil, M. A. U 2 ; Tan, J 3 ; Khan, T. F. T 4 

 Diaverum Prince Abdul Majeed Renal Centre, Jeddah 
 Department of Urology, Institute of Kidney Disease, Peshawar, KPK 
 Department Nephrology, RIPAS Hospital, Bander Seri Begawan 
 Department of Nephrology and Transplantation, King Salman Armed Forces Hospital, Tabuk 
Pages
257-264
Publication year
2018
Publication date
Jul/Aug 2018
Publisher
Scientific Scholar
ISSN
09714065
e-ISSN
19983662
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2087871741
Copyright
© 2018. This work is published under https://creativecommons.org/licenses/by-nc-sa/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.